(Q45856636)

17 December 2017

title

Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease (English)

1 reference

17 December 2017

1 reference

Dobrkovska A

1

1 reference

17 December 2017

Krzensk U

series ordinal

2

1 reference

17 December 2017

Chediak JR

series ordinal

3

1 reference

17 December 2017

publication date

1 January 1998

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

4 Suppl 3

1 reference

17 December 2017

page(s)

33-39

1 reference

17 December 2017

Von Willebrand factor: molecular size and functional activity

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

von Willebrand factor and platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Therapy of von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

In vitro and in vivo characterization of factor VIII preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

The effect of thrombin on the complex between factor VIII and von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Appendix I: Multimeric analysis of Von Willebrand factor and classification of Von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cryoprecipitate and different factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

The use of heat-treated Factor VIII-concentrates in von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Hemostatic effect of a heat-treated factor VIII concentrate (Haemate P) in von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

Use of a high-purity factor VIII concentrate (Hemate P) in von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3033.X

10.1046/J.1365-2516.1998.0040S3033.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017